Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million
The settlement does not resolve the tens of thousands of lawsuits alleging that J&J's talc-based products caused cancer. Source link
Read MoreThe settlement does not resolve the tens of thousands of lawsuits alleging that J&J's talc-based products caused cancer. Source link
Read MoreThese are the stocks posting the largest moves in premarket trading. Source link
Read MoreThe results come six months after J&J completed its spinoff of consumer health unit Kenvue, the company's biggest shake-up in
Read MoreTechnical analysts take the milestone as a bullish development for equities even amid lingering concerns of slowing economic growth. Source
Read MoreThe JPMorgan Healthcare Conference was likely just the beginning of another year of heightened interest and investments in ADC cancer
Read MoreThe deal, which was announced on the first day of the annual JPMorgan Healthcare Conference, makes J&J the latest drugmaker
Read MoreThis year's list is a bit more defensive than in years past and has a focus on earnings growth. Source
Read MoreNext year could set the precedent for the Inflation Reduction Act's controversial talks, which could affect dozens of medications by
Read MoreSome major companies, ranging from big pharma to oil and gas names, lost out on the Dow's rally this year.
Read More